NASHVILLE, Tenn., Sept. 26, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has entered into an ...
Harrow, Inc. (NASDAQ: HROW), a U.S.-based provider of ophthalmic disease management solutions, announced on Friday that it has agreed to acquire Melt Pharmaceuticals, Inc., a clinical-stage company ...
Please provide your email address to receive an email when new articles are posted on . Byooviz references Lucentis, and Opuviz references Eylea. Harrow expects the transaction to be completed by the ...
Video showing dustbins, pavements and roads splattered with deep red marks has gone viral. A video showing tobacco and paan spitting stains on the streets of London has gone viral. According to ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the third quarter and nine months ended September 30, 2024. The ...
Now, UK battles paan spitting. Viral video shows red stains on dustbins, pavements in Harrow, London
Chewing tobacco was once primarily a public nuisance in India, but now the frequent sight of red paan stains on streets and public spaces has gone global, manifesting a significant problem in Harrow, ...
NASHVILLE, Tenn. & TAIPEI, Taiwan--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals (“Formosa”, 6838.TW), today ...
Harrow focuses on ophthalmology products, including Iheezo, Vevye, and Triesence, but its clinical differentiation is debatable. HROW reported a record $48.9 million in Q2 revenue, a 46% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback